Suzetrigine is a medicine for short-term, moderate to severe pain, like pain after surgery. It is a pill taken by mouth. It works by blocking pain signals in the nerves before they reach the brain, and it is not an opioid.
Every report comes from a Lived member, sent anonymously.
Have you tried Journavx (Suzetrigine) for Pain After Surgery?
Suzetrigine, sold as Journavx, is a prescription pill for moderate to severe acute pain in adults, such as the pain in the days after surgery. Acute pain is short-term pain from an injury or procedure that is expected to fade as the body heals. Journavx is approved for that kind of pain only, not for long-term (chronic) pain, and it has not been studied for more than 14 days of use or in people under 18. It is not an opioid. The US Food and Drug Administration approved it in January 2025 as the first medicine in a new class of non-opioid pain relievers, which makes it an option for people who want to avoid or limit opioids such as hydrocodone or oxycodone. It is usually considered alongside other approaches, such as acetaminophen, anti-inflammatory medicines or opioids, rather than as a replacement for all of them.
Pain from an injury starts in sensory nerves throughout the body, which fire electrical signals that travel to the spinal cord and brain. Those signals depend on sodium channels, tiny gates that let sodium flow into the nerve cell. One type, called NaV1.8, is found mainly in the pain-sensing nerves outside the brain and spinal cord. Suzetrigine selectively blocks NaV1.8, so fewer pain signals leave the injured area. Because it works on these peripheral nerves rather than on the opioid receptors that opioid painkillers act on, it relieves pain by a different route. It dulls pain rather than removing it, and not every kind of pain depends on this pathway equally.
Journavx comes as a tablet taken by mouth. Treatment begins with a larger first dose, followed 12 hours later by a smaller dose every 12 hours. The first dose works fastest on an empty stomach, so it is taken at least 1 hour before or 2 hours after eating; clear liquids such as water, tea or black coffee are fine. Later doses can be taken with or without food. Swallow the tablets whole without chewing or crushing them. People with moderate liver disease, or who take certain interacting medicines (described under Interactions & Warnings), follow a reduced schedule, so it is worth checking the exact instructions on the prescription. The pharmacy label also explains what to do after a missed dose. It is meant to be used for the shortest time that controls the pain.
In the main trials, side effects were generally mild. The ones seen more often than with a placebo were itching, muscle spasms, rash and a rise in CPK (creatine phosphokinase), a muscle enzyme on blood tests that did not cause symptoms. In a pooled analysis of the trials, nausea and dizziness were actually less common than with placebo. Some people had a drop in eGFR, a blood-test estimate of how well the kidneys filter, which in one longer study appeared to return to normal by the final check-up. A rash that spreads or is accompanied by other new symptoms is worth reporting to the prescriber.
Suzetrigine is broken down by a liver enzyme called CYP3A, so medicines that block this enzyme can push its levels too high and raise the chance of side effects. It must not be taken with strong blockers, which include the antibiotic clarithromycin, the antifungals itraconazole and ketoconazole, and the HIV medicine ritonavir. With moderate blockers the dose is lowered. Grapefruit and grapefruit juice act in a similar way and should be avoided during treatment. Medicines that speed up CYP3A, such as rifampin (a tuberculosis antibiotic), carbamazepine (a seizure medicine) and the supplement St. John's wort, can make suzetrigine less effective and should be avoided. Suzetrigine can also lower the levels of some other medicines, so share a full list, including supplements, with the prescriber and pharmacist. It can make some hormonal birth control less reliable. If a pill, patch, ring, implant or injection contains a progestin other than levonorgestrel or norethindrone, use a backup nonhormonal method such as condoms, or switch methods, during treatment and for 28 days after the last dose. A pharmacist can confirm which progestin a given method contains. People with severe liver disease should not take it, and those with moderate liver disease need a lower dose. It is also avoided when kidney function is very low (an eGFR below 15, the level of kidney failure, which includes most people on dialysis); milder kidney disease does not change the dose. There is no information on its use in human pregnancy or breastfeeding; animal studies showed effects on pregnancy of uncertain relevance to people, so anyone pregnant, planning pregnancy or nursing should discuss it first.
Many people notice some relief within about an hour of the first dose. In the trials after surgery, meaningful relief (a drop of at least 2 points on a 0 to 10 pain scale) took a median of about 2 hours after a tummy tuck and about 4 hours after bunion surgery. Overall, pain was roughly 1 point lower on that scale with suzetrigine than with a placebo, a modest extra benefit on average on top of the relief people also felt with the placebo. Its strength compared with opioids depends on the situation. After a tummy tuck it was not clearly different from a low-dose hydrocodone and acetaminophen combination, but after bunion surgery it was less effective. Some people therefore still need other pain medicines alongside it. Whether it reduces how much opioid people end up using has not yet been shown. Treatment stops once the acute pain settles, and if pain remains severe or does not improve, the plan should be reviewed with the care team.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Journavx (Suzetrigine), what you've noticed, or ask the community a question.